Rare and Orphan Care for Biopharma Partners
With hyper-focused, personalized care at the very core of what we do, Biologics can manage the complex corners of the rare disease industry.
A trusted partner for rare and orphan drug launches
Biopharma support team
30 +
Years of expertise in the specialty pharmacy space, delivering
solutions for highly complex, orphan-designated therapies
25 +
The exclusive specialty pharmacy for over 25 life-changing drugs
21
Launch partner for 21 rare and ultra-rare therapies
5
Preferred dispensing provider for 5 cell and gene therapies
40 +
1 of 3 or fewer specialty pharmacy provider (SPP) LDD contracts
10
Integrated HUB programs
50 +
Robust licensing in all U.S. states and territories
Built on the foundation of deep clinical expertise and a high-touch approach to patient care, our strategic solutions for your orphan drug deliver seamless access and deep engagement.
Our leaders are clinicians who understand how to navigate the healthcare system for patients.
Supporting the rare and orphan commercialization process
As finding treatment options for these populations has become a priority, so too has the need for biopharma companies to identify and partner with specialty pharmacy providers that can serve the niche needs of their rare disease population with agility. The journey from clinical development to market access presents distinctive challenges. As biopharma begins to shift from clinical development and regulatory functions to their commercial planning, they must leverage their specialty pharmacy partners for commercial expertise residing within their selected partners.
The support a biopharma company gets from an experienced specialty pharmacy like Biologics is critical to the success of its drug in the marketplace. An effective launch enables the company to provide appropriate solutions to unmet needs, placing patients at the forefront of its commercialization strategy. This engagement—even in the early stages of commercial planning—ultimately powers the success of the brand. As more therapies become available for previously untreatable conditions, companies seek smooth commercialization paths in parallel with simplified treatment journeys for their patients.
We collaboratively support Biopharma partners by creating an ecosystem of services to:
Access & adherence
Seamless integration and optimal access to increase therapeutic outcomes.
Business intelligence, data, analytics
Comprehensive insights and advanced analytical tools to enable partners to make informed, strategic decisions and streamline operations.
Cell & gene strategies
Unparalleled expertise and support to ensure the successful development and delivery of transformative treatments.
Clinical & expanded access protocols
Guidance through the regulatory landscape, crafting tailored protocols that align with clinical objectives and patient access requirements.
Patient assistance programs & copay solutions
Personalized support to ensure that every patient has access to the therapies they need.
Therapy education & nursing support
Customized resources and expert guidance ensure that each patient fully understands their treatment journey at each step along the way.
Operational excellence & innovation
Risk evaluation & mitigation strategies (REMS)
You can always reach your care team if you have questions or need more information.
Overview & Support Services
Highlights Biologics' capabilities in connecting therapies with the right prescribers and patients.
Real-World Impact
Evidence-based examples showing how Biologics improves patient access and outcomes.
Financial & Access Resources
Foundational materials to support your overall collaboration with Biologics.